Telix Pharmaceuticals Limited TLX

Set alert

Price alert · TLX

All alert types
9.08 USD +0.03 +0.33%

As of Nov 3, 10:55 AM ET

Bid
9.06 × 3
Ask
9.08 × 1
9.01 Day range 9.09
6.28 52-week range 13.11
YTD
+21.23%
1 year
-12.61%
Open
9.05
Prev close
9.05
Mkt cap
3.08B
Vol
55.99K
Avg vol
323.44K
EPS
0.10
P/E
90.80
Div yield
0.00%
More statistics
Low
9.01
High
9.09
Forward P/E
-338.83
Beta
0.63
Short ratio
0.76
Inst. own
1.02%
Dividend
0.00
Ex-div date
Earnings
Feb 19, 2027
50-d avg
11.05
200-d avg
9.90
1y target
20.45

3M chart

Chart tools
Interval

Events in this range
  • Aug 19, 2026Earnings: 0.1074; estimate 0.0447; surprise 140.27%
  • Sep 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 14, 2026Rating: Wedbush · Outperform → Outperform
  • Sep 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 23, 2026Rating: Wedbush · Outperform → Outperform
  • Sep 25, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 21, 2026Rating: Wedbush · Outperform → Outperform
Signals (21)
NameDateAgo
MACD: Sell SignalOct 21, 20261 week ago
MACD: Buy SignalOct 20, 20262 weeks ago
SMA: BearishSep 29, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 21, 20261 month ago
MACD: Buy SignalSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 11, 20261 month ago
MACD: Sell SignalSep 11, 20261 month ago
MACD: Buy SignalSep 8, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishAug 31, 20262 months ago
MACD: Sell SignalAug 26, 20262 months ago
RSI: OverboughtAug 13, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago

Newest 20 of 21.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 20.45 +125.2% upside
Target (low)
17.91
Target (mean)
20.45
Target (high)
21.94
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TLX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.0860.086 – 0.0860.000.0%329.36M+3.6%1
Next quarter0.0860.086 – 0.0860.000.0%318.75M+2.9%1
Current year0.16140.026 – 0.429-0.0299+639.8%1.39B+16.2%5
Next year-0.038-0.051 – -0.0250.1614-123.5%1.57B+13.1%2

Upgrades and downgrades

The latest rating changes

TLX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026WedbushReiteratedOutperformOutperform
Sep 25, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2026WedbushReiteratedOutperformOutperform
Sep 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 14, 2026WedbushReiteratedOutperformOutperform
Sep 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 20, 2026WedbushReiteratedOutperformOutperform
Jul 7, 2026CitigroupMaintainedBuyBuy
Jul 7, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 6, 2026WedbushReiteratedOutperformOutperform
Apr 13, 2026WedbushReiteratedOutperformOutperform
Apr 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 7, 2026WedbushReiteratedOutperformOutperform
Apr 7, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 24, 2026CitigroupMaintainedBuyBuy
Jan 21, 2026HC Wainwright & Co.ReiteratedBuyBuy
Dec 22, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2025UBSMaintainedBuyBuy
Sep 18, 2025CitigroupInitiated—Buy
Sep 10, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 28, 2025JP MorganDowngradeOverweightNeutral
Aug 28, 2025WedbushReiteratedOutperformOutperform
Jul 3, 2025HC Wainwright & Co.Initiated—Buy
Jun 12, 2025WedbushReiteratedOutperformOutperform
Jun 5, 2025WedbushInitiated—Outperform
Jan 27, 2025UBSMaintainedBuyBuy
Nov 15, 2024UBSInitiated—Buy